Watson Pharmaceuticals, Inc. to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference

Published: Aug 29, 2012

PARSIPPANY, N.J., Aug. 29, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2012 Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, September 12, 2012 at 10:25AM Eastern Time (3:25PM London Time) at Merrill Lynch Financial Center in London. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL:

http://www.media-server.com/m/p/8qogd5t2

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology. Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

CONTACTS:

Investors:
Lisa DeFrancesco
(862) 261-7152

Media:
Charlie Mayr
(862) 261-8030

SOURCE Watson Pharmaceuticals, Inc.

Back to news